<SEC-DOCUMENT>0001583977-20-000001.txt : 20200214
<SEC-HEADER>0001583977-20-000001.hdr.sgml : 20200214
<ACCEPTANCE-DATETIME>20200214153657
ACCESSION NUMBER:		0001583977-20-000001
CONFORMED SUBMISSION TYPE:	13F-HR
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20191231
FILED AS OF DATE:		20200214
DATE AS OF CHANGE:		20200214
EFFECTIVENESS DATE:		20200214

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Cormorant Asset Management, LP
		CENTRAL INDEX KEY:			0001583977
		IRS NUMBER:				462108927
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		13F-HR
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	028-15949
		FILM NUMBER:		20618821

	BUSINESS ADDRESS:	
		STREET 1:		200 CLARENDON STREET
		STREET 2:		52ND FLOOR
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02116
		BUSINESS PHONE:		857-702-0388

	MAIL ADDRESS:	
		STREET 1:		200 CLARENDON STREET
		STREET 2:		52ND FLOOR
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02116

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Cormorant Asset Management, LLC
		DATE OF NAME CHANGE:	20130807
</SEC-HEADER>
<DOCUMENT>
<TYPE>13F-HR
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="UTF-8"?>
<edgarSubmission xmlns="http://www.sec.gov/edgar/thirteenffiler" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>13F-HR</submissionType>
    <filerInfo>
      <liveTestFlag>LIVE</liveTestFlag>
      <flags>
        <confirmingCopyFlag>false</confirmingCopyFlag>
        <returnCopyFlag>false</returnCopyFlag>
        <overrideInternetFlag>false</overrideInternetFlag>
      </flags>
      <filer>
        <credentials>
          <cik>0001583977</cik>
          <ccc>XXXXXXXX</ccc>
        </credentials>
      </filer>
      <periodOfReport>12-31-2019</periodOfReport>
    </filerInfo>
  </headerData>
  <formData>
    <coverPage>
      <reportCalendarOrQuarter>12-31-2019</reportCalendarOrQuarter>
      <filingManager>
        <name>Cormorant Asset Management, LP</name>
        <address>
          <com:street1>200 CLARENDON STREET</com:street1>
          <com:street2>52ND FLOOR</com:street2>
          <com:city>BOSTON</com:city>
          <com:stateOrCountry>MA</com:stateOrCountry>
          <com:zipCode>02116</com:zipCode>
        </address>
      </filingManager>
      <reportType>13F HOLDINGS REPORT</reportType>
      <form13FFileNumber>028-15949</form13FFileNumber>
      <provideInfoForInstruction5>N</provideInfoForInstruction5>
    </coverPage>
    <signatureBlock>
      <name>Neb Obradovic</name>
      <title>CCO</title>
      <phone>857-702-0370</phone>
      <signature>/s/ Neb Obradovic</signature>
      <city>Boston</city>
      <stateOrCountry>MA</stateOrCountry>
      <signatureDate>02-14-2020</signatureDate>
    </signatureBlock>
    <summaryPage>
      <otherIncludedManagersCount>1</otherIncludedManagersCount>
      <tableEntryTotal>67</tableEntryTotal>
      <tableValueTotal>2505998</tableValueTotal>
      <isConfidentialOmitted>false</isConfidentialOmitted>
      <otherManagers2Info>
        <otherManager2>
          <sequenceNumber>1</sequenceNumber>
          <otherManager>
            <cik>0001599214</cik>
            <form13FFileNumber>028-15950</form13FFileNumber>
            <name>Chen Bihua</name>
          </otherManager>
        </otherManager2>
      </otherManagers2Info>
    </summaryPage>
  </formData>
</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>INFORMATION TABLE
<SEQUENCE>2
<FILENAME>cam13f123119.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<ns1:informationTable xmlns:ns1="http://www.sec.gov/edgar/document/thirteenf/informationtable">
	<ns1:infoTable>
		<ns1:nameOfIssuer>AKERO THERAPEUTICS INC</ns1:nameOfIssuer>
		<ns1:titleOfClass>COM</ns1:titleOfClass>
		<ns1:cusip>00973Y108</ns1:cusip>
		<ns1:value>16438</ns1:value>
		<ns1:shrsOrPrnAmt>
			<ns1:sshPrnamt>740621</ns1:sshPrnamt>
			<ns1:sshPrnamtType>SH</ns1:sshPrnamtType>
		</ns1:shrsOrPrnAmt>
		<ns1:investmentDiscretion>DFND</ns1:investmentDiscretion>
		<ns1:otherManager>1</ns1:otherManager>
		<ns1:votingAuthority>
			<ns1:Sole>740621</ns1:Sole>
			<ns1:Shared>0</ns1:Shared>
			<ns1:None>0</ns1:None>
		</ns1:votingAuthority>
	</ns1:infoTable>
	<ns1:infoTable>
		<ns1:nameOfIssuer>ALLAKOS INC</ns1:nameOfIssuer>
		<ns1:titleOfClass>COM</ns1:titleOfClass>
		<ns1:cusip>01671P100</ns1:cusip>
		<ns1:value>28608</ns1:value>
		<ns1:shrsOrPrnAmt>
			<ns1:sshPrnamt>300000</ns1:sshPrnamt>
			<ns1:sshPrnamtType>SH</ns1:sshPrnamtType>
		</ns1:shrsOrPrnAmt>
		<ns1:investmentDiscretion>DFND</ns1:investmentDiscretion>
		<ns1:otherManager>1</ns1:otherManager>
		<ns1:votingAuthority>
			<ns1:Sole>300000</ns1:Sole>
			<ns1:Shared>0</ns1:Shared>
			<ns1:None>0</ns1:None>
		</ns1:votingAuthority>
	</ns1:infoTable>
	<ns1:infoTable>
		<ns1:nameOfIssuer>AMARIN CORP PLC</ns1:nameOfIssuer>
		<ns1:titleOfClass>SPONS ADR NEW</ns1:titleOfClass>
		<ns1:cusip>023111206</ns1:cusip>
		<ns1:value>27872</ns1:value>
		<ns1:shrsOrPrnAmt>
			<ns1:sshPrnamt>1300000</ns1:sshPrnamt>
			<ns1:sshPrnamtType>SH</ns1:sshPrnamtType>
		</ns1:shrsOrPrnAmt>
		<ns1:investmentDiscretion>DFND</ns1:investmentDiscretion>
		<ns1:otherManager>1</ns1:otherManager>
		<ns1:votingAuthority>
			<ns1:Sole>1300000</ns1:Sole>
			<ns1:Shared>0</ns1:Shared>
			<ns1:None>0</ns1:None>
		</ns1:votingAuthority>
	</ns1:infoTable>
	<ns1:infoTable>
		<ns1:nameOfIssuer>ANAPTYSBIO INC</ns1:nameOfIssuer>
		<ns1:titleOfClass>COM</ns1:titleOfClass>
		<ns1:cusip>032724106</ns1:cusip>
		<ns1:value>5931</ns1:value>
		<ns1:shrsOrPrnAmt>
			<ns1:sshPrnamt>365000</ns1:sshPrnamt>
			<ns1:sshPrnamtType>SH</ns1:sshPrnamtType>
		</ns1:shrsOrPrnAmt>
		<ns1:investmentDiscretion>DFND</ns1:investmentDiscretion>
		<ns1:otherManager>1</ns1:otherManager>
		<ns1:votingAuthority>
			<ns1:Sole>365000</ns1:Sole>
			<ns1:Shared>0</ns1:Shared>
			<ns1:None>0</ns1:None>
		</ns1:votingAuthority>
	</ns1:infoTable>
	<ns1:infoTable>
		<ns1:nameOfIssuer>APELLIS PHARMACEUTICALS INC</ns1:nameOfIssuer>
		<ns1:titleOfClass>COM</ns1:titleOfClass>
		<ns1:cusip>03753U106</ns1:cusip>
		<ns1:value>82674</ns1:value>
		<ns1:shrsOrPrnAmt>
			<ns1:sshPrnamt>2700000</ns1:sshPrnamt>
			<ns1:sshPrnamtType>SH</ns1:sshPrnamtType>
		</ns1:shrsOrPrnAmt>
		<ns1:investmentDiscretion>DFND</ns1:investmentDiscretion>
		<ns1:otherManager>1</ns1:otherManager>
		<ns1:votingAuthority>
			<ns1:Sole>2700000</ns1:Sole>
			<ns1:Shared>0</ns1:Shared>
			<ns1:None>0</ns1:None>
		</ns1:votingAuthority>
	</ns1:infoTable>
	<ns1:infoTable>
		<ns1:nameOfIssuer>ARENA PHARMACEUTICALS INC</ns1:nameOfIssuer>
		<ns1:titleOfClass>COM NEW</ns1:titleOfClass>
		<ns1:cusip>040047607</ns1:cusip>
		<ns1:value>7826</ns1:value>
		<ns1:shrsOrPrnAmt>
			<ns1:sshPrnamt>172300</ns1:sshPrnamt>
			<ns1:sshPrnamtType>SH</ns1:sshPrnamtType>
		</ns1:shrsOrPrnAmt>
		<ns1:investmentDiscretion>DFND</ns1:investmentDiscretion>
		<ns1:otherManager>1</ns1:otherManager>
		<ns1:votingAuthority>
			<ns1:Sole>172300</ns1:Sole>
			<ns1:Shared>0</ns1:Shared>
			<ns1:None>0</ns1:None>
		</ns1:votingAuthority>
	</ns1:infoTable>
	<ns1:infoTable>
		<ns1:nameOfIssuer>ARGENX SE</ns1:nameOfIssuer>
		<ns1:titleOfClass>SPONSORED ADR</ns1:titleOfClass>
		<ns1:cusip>04016X101</ns1:cusip>
		<ns1:value>16052</ns1:value>
		<ns1:shrsOrPrnAmt>
			<ns1:sshPrnamt>100000</ns1:sshPrnamt>
			<ns1:sshPrnamtType>SH</ns1:sshPrnamtType>
		</ns1:shrsOrPrnAmt>
		<ns1:investmentDiscretion>DFND</ns1:investmentDiscretion>
		<ns1:otherManager>1</ns1:otherManager>
		<ns1:votingAuthority>
			<ns1:Sole>100000</ns1:Sole>
			<ns1:Shared>0</ns1:Shared>
			<ns1:None>0</ns1:None>
		</ns1:votingAuthority>
	</ns1:infoTable>
	<ns1:infoTable>
		<ns1:nameOfIssuer>ASCENDIS PHARMA A S</ns1:nameOfIssuer>
		<ns1:titleOfClass>SPONSORED ADR</ns1:titleOfClass>
		<ns1:cusip>04351P101</ns1:cusip>
		<ns1:value>55648</ns1:value>
		<ns1:shrsOrPrnAmt>
			<ns1:sshPrnamt>400000</ns1:sshPrnamt>
			<ns1:sshPrnamtType>SH</ns1:sshPrnamtType>
		</ns1:shrsOrPrnAmt>
		<ns1:investmentDiscretion>DFND</ns1:investmentDiscretion>
		<ns1:otherManager>1</ns1:otherManager>
		<ns1:votingAuthority>
			<ns1:Sole>400000</ns1:Sole>
			<ns1:Shared>0</ns1:Shared>
			<ns1:None>0</ns1:None>
		</ns1:votingAuthority>
	</ns1:infoTable>
	<ns1:infoTable>
		<ns1:nameOfIssuer>ASCENDIS PHARMA A S</ns1:nameOfIssuer>
		<ns1:titleOfClass>SPONSORED ADR</ns1:titleOfClass>
		<ns1:cusip>04351P101</ns1:cusip>
		<ns1:value>34780</ns1:value>
		<ns1:shrsOrPrnAmt>
			<ns1:sshPrnamt>250000</ns1:sshPrnamt>
			<ns1:sshPrnamtType>SH</ns1:sshPrnamtType>
		</ns1:shrsOrPrnAmt>
		<ns1:putCall>Call</ns1:putCall>
		<ns1:investmentDiscretion>DFND</ns1:investmentDiscretion>
		<ns1:otherManager>1</ns1:otherManager>
		<ns1:votingAuthority>
			<ns1:Sole>250000</ns1:Sole>
			<ns1:Shared>0</ns1:Shared>
			<ns1:None>0</ns1:None>
		</ns1:votingAuthority>
	</ns1:infoTable>
	<ns1:infoTable>
		<ns1:nameOfIssuer>ATRECA INC</ns1:nameOfIssuer>
		<ns1:titleOfClass>CL A COM</ns1:titleOfClass>
		<ns1:cusip>04965G109</ns1:cusip>
		<ns1:value>5045</ns1:value>
		<ns1:shrsOrPrnAmt>
			<ns1:sshPrnamt>326141</ns1:sshPrnamt>
			<ns1:sshPrnamtType>SH</ns1:sshPrnamtType>
		</ns1:shrsOrPrnAmt>
		<ns1:investmentDiscretion>DFND</ns1:investmentDiscretion>
		<ns1:otherManager>1</ns1:otherManager>
		<ns1:votingAuthority>
			<ns1:Sole>326141</ns1:Sole>
			<ns1:Shared>0</ns1:Shared>
			<ns1:None>0</ns1:None>
		</ns1:votingAuthority>
	</ns1:infoTable>
	<ns1:infoTable>
		<ns1:nameOfIssuer>AUTOLUS THERAPEUTICS PLC</ns1:nameOfIssuer>
		<ns1:titleOfClass>SPON ADS</ns1:titleOfClass>
		<ns1:cusip>05280R100</ns1:cusip>
		<ns1:value>6336</ns1:value>
		<ns1:shrsOrPrnAmt>
			<ns1:sshPrnamt>479988</ns1:sshPrnamt>
			<ns1:sshPrnamtType>SH</ns1:sshPrnamtType>
		</ns1:shrsOrPrnAmt>
		<ns1:investmentDiscretion>DFND</ns1:investmentDiscretion>
		<ns1:otherManager>1</ns1:otherManager>
		<ns1:votingAuthority>
			<ns1:Sole>479988</ns1:Sole>
			<ns1:Shared>0</ns1:Shared>
			<ns1:None>0</ns1:None>
		</ns1:votingAuthority>
	</ns1:infoTable>
	<ns1:infoTable>
		<ns1:nameOfIssuer>AVROBIO INC</ns1:nameOfIssuer>
		<ns1:titleOfClass>COM</ns1:titleOfClass>
		<ns1:cusip>05455M100</ns1:cusip>
		<ns1:value>6393</ns1:value>
		<ns1:shrsOrPrnAmt>
			<ns1:sshPrnamt>317579</ns1:sshPrnamt>
			<ns1:sshPrnamtType>SH</ns1:sshPrnamtType>
		</ns1:shrsOrPrnAmt>
		<ns1:investmentDiscretion>DFND</ns1:investmentDiscretion>
		<ns1:otherManager>1</ns1:otherManager>
		<ns1:votingAuthority>
			<ns1:Sole>317579</ns1:Sole>
			<ns1:Shared>0</ns1:Shared>
			<ns1:None>0</ns1:None>
		</ns1:votingAuthority>
	</ns1:infoTable>
	<ns1:infoTable>
		<ns1:nameOfIssuer>AXONICS MODULATION TECH INC</ns1:nameOfIssuer>
		<ns1:titleOfClass>COM</ns1:titleOfClass>
		<ns1:cusip>05465P101</ns1:cusip>
		<ns1:value>33880</ns1:value>
		<ns1:shrsOrPrnAmt>
			<ns1:sshPrnamt>1222671</ns1:sshPrnamt>
			<ns1:sshPrnamtType>SH</ns1:sshPrnamtType>
		</ns1:shrsOrPrnAmt>
		<ns1:investmentDiscretion>DFND</ns1:investmentDiscretion>
		<ns1:otherManager>1</ns1:otherManager>
		<ns1:votingAuthority>
			<ns1:Sole>1222671</ns1:Sole>
			<ns1:Shared>0</ns1:Shared>
			<ns1:None>0</ns1:None>
		</ns1:votingAuthority>
	</ns1:infoTable>
	<ns1:infoTable>
		<ns1:nameOfIssuer>AXSOME THERAPEUTICS INC</ns1:nameOfIssuer>
		<ns1:titleOfClass>COM</ns1:titleOfClass>
		<ns1:cusip>05464T104</ns1:cusip>
		<ns1:value>62016</ns1:value>
		<ns1:shrsOrPrnAmt>
			<ns1:sshPrnamt>600000</ns1:sshPrnamt>
			<ns1:sshPrnamtType>SH</ns1:sshPrnamtType>
		</ns1:shrsOrPrnAmt>
		<ns1:investmentDiscretion>DFND</ns1:investmentDiscretion>
		<ns1:otherManager>1</ns1:otherManager>
		<ns1:votingAuthority>
			<ns1:Sole>600000</ns1:Sole>
			<ns1:Shared>0</ns1:Shared>
			<ns1:None>0</ns1:None>
		</ns1:votingAuthority>
	</ns1:infoTable>
	<ns1:infoTable>
		<ns1:nameOfIssuer>BIOHAVEN PHARMACTL HLDG CO L</ns1:nameOfIssuer>
		<ns1:titleOfClass>COM</ns1:titleOfClass>
		<ns1:cusip>G11196105</ns1:cusip>
		<ns1:value>54440</ns1:value>
		<ns1:shrsOrPrnAmt>
			<ns1:sshPrnamt>1000000</ns1:sshPrnamt>
			<ns1:sshPrnamtType>SH</ns1:sshPrnamtType>
		</ns1:shrsOrPrnAmt>
		<ns1:investmentDiscretion>DFND</ns1:investmentDiscretion>
		<ns1:otherManager>1</ns1:otherManager>
		<ns1:votingAuthority>
			<ns1:Sole>1000000</ns1:Sole>
			<ns1:Shared>0</ns1:Shared>
			<ns1:None>0</ns1:None>
		</ns1:votingAuthority>
	</ns1:infoTable>
	<ns1:infoTable>
		<ns1:nameOfIssuer>BIOHAVEN PHARMACTL HLDG CO L</ns1:nameOfIssuer>
		<ns1:titleOfClass>COM</ns1:titleOfClass>
		<ns1:cusip>G11196105</ns1:cusip>
		<ns1:value>27220</ns1:value>
		<ns1:shrsOrPrnAmt>
			<ns1:sshPrnamt>500000</ns1:sshPrnamt>
			<ns1:sshPrnamtType>SH</ns1:sshPrnamtType>
		</ns1:shrsOrPrnAmt>
		<ns1:putCall>Call</ns1:putCall>
		<ns1:investmentDiscretion>DFND</ns1:investmentDiscretion>
		<ns1:otherManager>1</ns1:otherManager>
		<ns1:votingAuthority>
			<ns1:Sole>500000</ns1:Sole>
			<ns1:Shared>0</ns1:Shared>
			<ns1:None>0</ns1:None>
		</ns1:votingAuthority>
	</ns1:infoTable>
	<ns1:infoTable>
		<ns1:nameOfIssuer>BLUEPRINT MEDICINES CORP</ns1:nameOfIssuer>
		<ns1:titleOfClass>COM</ns1:titleOfClass>
		<ns1:cusip>09627Y109</ns1:cusip>
		<ns1:value>27638</ns1:value>
		<ns1:shrsOrPrnAmt>
			<ns1:sshPrnamt>345000</ns1:sshPrnamt>
			<ns1:sshPrnamtType>SH</ns1:sshPrnamtType>
		</ns1:shrsOrPrnAmt>
		<ns1:investmentDiscretion>DFND</ns1:investmentDiscretion>
		<ns1:otherManager>1</ns1:otherManager>
		<ns1:votingAuthority>
			<ns1:Sole>345000</ns1:Sole>
			<ns1:Shared>0</ns1:Shared>
			<ns1:None>0</ns1:None>
		</ns1:votingAuthority>
	</ns1:infoTable>
	<ns1:infoTable>
		<ns1:nameOfIssuer>BRIDGEBIO PHARMA INC</ns1:nameOfIssuer>
		<ns1:titleOfClass>COM</ns1:titleOfClass>
		<ns1:cusip>10806X102</ns1:cusip>
		<ns1:value>88076</ns1:value>
		<ns1:shrsOrPrnAmt>
			<ns1:sshPrnamt>2512865</ns1:sshPrnamt>
			<ns1:sshPrnamtType>SH</ns1:sshPrnamtType>
		</ns1:shrsOrPrnAmt>
		<ns1:investmentDiscretion>DFND</ns1:investmentDiscretion>
		<ns1:otherManager>1</ns1:otherManager>
		<ns1:votingAuthority>
			<ns1:Sole>2512865</ns1:Sole>
			<ns1:Shared>0</ns1:Shared>
			<ns1:None>0</ns1:None>
		</ns1:votingAuthority>
	</ns1:infoTable>
	<ns1:infoTable>
		<ns1:nameOfIssuer>CABALETTA BIO INC</ns1:nameOfIssuer>
		<ns1:titleOfClass>COM</ns1:titleOfClass>
		<ns1:cusip>12674W109</ns1:cusip>
		<ns1:value>29604</ns1:value>
		<ns1:shrsOrPrnAmt>
			<ns1:sshPrnamt>2119132</ns1:sshPrnamt>
			<ns1:sshPrnamtType>SH</ns1:sshPrnamtType>
		</ns1:shrsOrPrnAmt>
		<ns1:investmentDiscretion>DFND</ns1:investmentDiscretion>
		<ns1:otherManager>1</ns1:otherManager>
		<ns1:votingAuthority>
			<ns1:Sole>2119132</ns1:Sole>
			<ns1:Shared>0</ns1:Shared>
			<ns1:None>0</ns1:None>
		</ns1:votingAuthority>
	</ns1:infoTable>
	<ns1:infoTable>
		<ns1:nameOfIssuer>CHEMOCENTRYX INC</ns1:nameOfIssuer>
		<ns1:titleOfClass>COM</ns1:titleOfClass>
		<ns1:cusip>16383L106</ns1:cusip>
		<ns1:value>114695</ns1:value>
		<ns1:shrsOrPrnAmt>
			<ns1:sshPrnamt>2900000</ns1:sshPrnamt>
			<ns1:sshPrnamtType>SH</ns1:sshPrnamtType>
		</ns1:shrsOrPrnAmt>
		<ns1:investmentDiscretion>DFND</ns1:investmentDiscretion>
		<ns1:otherManager>1</ns1:otherManager>
		<ns1:votingAuthority>
			<ns1:Sole>2900000</ns1:Sole>
			<ns1:Shared>0</ns1:Shared>
			<ns1:None>0</ns1:None>
		</ns1:votingAuthority>
	</ns1:infoTable>
	<ns1:infoTable>
		<ns1:nameOfIssuer>CHEMOCENTRYX INC</ns1:nameOfIssuer>
		<ns1:titleOfClass>COM</ns1:titleOfClass>
		<ns1:cusip>16383L106</ns1:cusip>
		<ns1:value>9888</ns1:value>
		<ns1:shrsOrPrnAmt>
			<ns1:sshPrnamt>250000</ns1:sshPrnamt>
			<ns1:sshPrnamtType>SH</ns1:sshPrnamtType>
		</ns1:shrsOrPrnAmt>
		<ns1:putCall>Call</ns1:putCall>
		<ns1:investmentDiscretion>DFND</ns1:investmentDiscretion>
		<ns1:otherManager>1</ns1:otherManager>
		<ns1:votingAuthority>
			<ns1:Sole>250000</ns1:Sole>
			<ns1:Shared>0</ns1:Shared>
			<ns1:None>0</ns1:None>
		</ns1:votingAuthority>
	</ns1:infoTable>
	<ns1:infoTable>
		<ns1:nameOfIssuer>CONSTELLATION PHARMCETICLS I</ns1:nameOfIssuer>
		<ns1:titleOfClass>COM</ns1:titleOfClass>
		<ns1:cusip>210373106</ns1:cusip>
		<ns1:value>108353</ns1:value>
		<ns1:shrsOrPrnAmt>
			<ns1:sshPrnamt>2300000</ns1:sshPrnamt>
			<ns1:sshPrnamtType>SH</ns1:sshPrnamtType>
		</ns1:shrsOrPrnAmt>
		<ns1:investmentDiscretion>DFND</ns1:investmentDiscretion>
		<ns1:otherManager>1</ns1:otherManager>
		<ns1:votingAuthority>
			<ns1:Sole>2300000</ns1:Sole>
			<ns1:Shared>0</ns1:Shared>
			<ns1:None>0</ns1:None>
		</ns1:votingAuthority>
	</ns1:infoTable>
	<ns1:infoTable>
		<ns1:nameOfIssuer>CRISPR THERAPEUTICS AG</ns1:nameOfIssuer>
		<ns1:titleOfClass>NAMEN AKT</ns1:titleOfClass>
		<ns1:cusip>H17182108</ns1:cusip>
		<ns1:value>60905</ns1:value>
		<ns1:shrsOrPrnAmt>
			<ns1:sshPrnamt>1000000</ns1:sshPrnamt>
			<ns1:sshPrnamtType>SH</ns1:sshPrnamtType>
		</ns1:shrsOrPrnAmt>
		<ns1:investmentDiscretion>DFND</ns1:investmentDiscretion>
		<ns1:otherManager>1</ns1:otherManager>
		<ns1:votingAuthority>
			<ns1:Sole>1000000</ns1:Sole>
			<ns1:Shared>0</ns1:Shared>
			<ns1:None>0</ns1:None>
		</ns1:votingAuthority>
	</ns1:infoTable>
	<ns1:infoTable>
		<ns1:nameOfIssuer>DECIPHERA PHARMACEUTICALS IN</ns1:nameOfIssuer>
		<ns1:titleOfClass>COM</ns1:titleOfClass>
		<ns1:cusip>24344T101</ns1:cusip>
		<ns1:value>28008</ns1:value>
		<ns1:shrsOrPrnAmt>
			<ns1:sshPrnamt>450000</ns1:sshPrnamt>
			<ns1:sshPrnamtType>SH</ns1:sshPrnamtType>
		</ns1:shrsOrPrnAmt>
		<ns1:investmentDiscretion>DFND</ns1:investmentDiscretion>
		<ns1:otherManager>1</ns1:otherManager>
		<ns1:votingAuthority>
			<ns1:Sole>450000</ns1:Sole>
			<ns1:Shared>0</ns1:Shared>
			<ns1:None>0</ns1:None>
		</ns1:votingAuthority>
	</ns1:infoTable>
	<ns1:infoTable>
		<ns1:nameOfIssuer>EIDOS THERAPEUTICS INC</ns1:nameOfIssuer>
		<ns1:titleOfClass>COM</ns1:titleOfClass>
		<ns1:cusip>28249H104</ns1:cusip>
		<ns1:value>28448</ns1:value>
		<ns1:shrsOrPrnAmt>
			<ns1:sshPrnamt>495692</ns1:sshPrnamt>
			<ns1:sshPrnamtType>SH</ns1:sshPrnamtType>
		</ns1:shrsOrPrnAmt>
		<ns1:investmentDiscretion>DFND</ns1:investmentDiscretion>
		<ns1:otherManager>1</ns1:otherManager>
		<ns1:votingAuthority>
			<ns1:Sole>495692</ns1:Sole>
			<ns1:Shared>0</ns1:Shared>
			<ns1:None>0</ns1:None>
		</ns1:votingAuthority>
	</ns1:infoTable>
	<ns1:infoTable>
		<ns1:nameOfIssuer>EIGER BIOPHARMACEUTICALS INC</ns1:nameOfIssuer>
		<ns1:titleOfClass>COM</ns1:titleOfClass>
		<ns1:cusip>28249U105</ns1:cusip>
		<ns1:value>12418</ns1:value>
		<ns1:shrsOrPrnAmt>
			<ns1:sshPrnamt>833400</ns1:sshPrnamt>
			<ns1:sshPrnamtType>SH</ns1:sshPrnamtType>
		</ns1:shrsOrPrnAmt>
		<ns1:investmentDiscretion>DFND</ns1:investmentDiscretion>
		<ns1:otherManager>1</ns1:otherManager>
		<ns1:votingAuthority>
			<ns1:Sole>833400</ns1:Sole>
			<ns1:Shared>0</ns1:Shared>
			<ns1:None>0</ns1:None>
		</ns1:votingAuthority>
	</ns1:infoTable>
	<ns1:infoTable>
		<ns1:nameOfIssuer>GALAPAGOS NV</ns1:nameOfIssuer>
		<ns1:titleOfClass>SPON ADR</ns1:titleOfClass>
		<ns1:cusip>36315X101</ns1:cusip>
		<ns1:value>20921</ns1:value>
		<ns1:shrsOrPrnAmt>
			<ns1:sshPrnamt>100000</ns1:sshPrnamt>
			<ns1:sshPrnamtType>SH</ns1:sshPrnamtType>
		</ns1:shrsOrPrnAmt>
		<ns1:investmentDiscretion>DFND</ns1:investmentDiscretion>
		<ns1:otherManager>1</ns1:otherManager>
		<ns1:votingAuthority>
			<ns1:Sole>100000</ns1:Sole>
			<ns1:Shared>0</ns1:Shared>
			<ns1:None>0</ns1:None>
		</ns1:votingAuthority>
	</ns1:infoTable>
	<ns1:infoTable>
		<ns1:nameOfIssuer>GOSSAMER BIO INC</ns1:nameOfIssuer>
		<ns1:titleOfClass>COM</ns1:titleOfClass>
		<ns1:cusip>38341P102</ns1:cusip>
		<ns1:value>4689</ns1:value>
		<ns1:shrsOrPrnAmt>
			<ns1:sshPrnamt>300000</ns1:sshPrnamt>
			<ns1:sshPrnamtType>SH</ns1:sshPrnamtType>
		</ns1:shrsOrPrnAmt>
		<ns1:investmentDiscretion>DFND</ns1:investmentDiscretion>
		<ns1:otherManager>1</ns1:otherManager>
		<ns1:votingAuthority>
			<ns1:Sole>300000</ns1:Sole>
			<ns1:Shared>0</ns1:Shared>
			<ns1:None>0</ns1:None>
		</ns1:votingAuthority>
	</ns1:infoTable>
	<ns1:infoTable>
		<ns1:nameOfIssuer>HARPOON THERAPEUTICS INC</ns1:nameOfIssuer>
		<ns1:titleOfClass>COM</ns1:titleOfClass>
		<ns1:cusip>41358P106</ns1:cusip>
		<ns1:value>9613</ns1:value>
		<ns1:shrsOrPrnAmt>
			<ns1:sshPrnamt>649994</ns1:sshPrnamt>
			<ns1:sshPrnamtType>SH</ns1:sshPrnamtType>
		</ns1:shrsOrPrnAmt>
		<ns1:investmentDiscretion>DFND</ns1:investmentDiscretion>
		<ns1:otherManager>1</ns1:otherManager>
		<ns1:votingAuthority>
			<ns1:Sole>649994</ns1:Sole>
			<ns1:Shared>0</ns1:Shared>
			<ns1:None>0</ns1:None>
		</ns1:votingAuthority>
	</ns1:infoTable>
	<ns1:infoTable>
		<ns1:nameOfIssuer>IGM BIOSCIENCES INC</ns1:nameOfIssuer>
		<ns1:titleOfClass>COM</ns1:titleOfClass>
		<ns1:cusip>449585108</ns1:cusip>
		<ns1:value>5968</ns1:value>
		<ns1:shrsOrPrnAmt>
			<ns1:sshPrnamt>156400</ns1:sshPrnamt>
			<ns1:sshPrnamtType>SH</ns1:sshPrnamtType>
		</ns1:shrsOrPrnAmt>
		<ns1:investmentDiscretion>DFND</ns1:investmentDiscretion>
		<ns1:otherManager>1</ns1:otherManager>
		<ns1:votingAuthority>
			<ns1:Sole>156400</ns1:Sole>
			<ns1:Shared>0</ns1:Shared>
			<ns1:None>0</ns1:None>
		</ns1:votingAuthority>
	</ns1:infoTable>
	<ns1:infoTable>
		<ns1:nameOfIssuer>IMMUNOVANT INC</ns1:nameOfIssuer>
		<ns1:titleOfClass>UNIT 12/18/2024</ns1:titleOfClass>
		<ns1:cusip>45258J201</ns1:cusip>
		<ns1:value>26548</ns1:value>
		<ns1:shrsOrPrnAmt>
			<ns1:sshPrnamt>1080000</ns1:sshPrnamt>
			<ns1:sshPrnamtType>SH</ns1:sshPrnamtType>
		</ns1:shrsOrPrnAmt>
		<ns1:investmentDiscretion>DFND</ns1:investmentDiscretion>
		<ns1:otherManager>1</ns1:otherManager>
		<ns1:votingAuthority>
			<ns1:Sole>1080000</ns1:Sole>
			<ns1:Shared>0</ns1:Shared>
			<ns1:None>0</ns1:None>
		</ns1:votingAuthority>
	</ns1:infoTable>
	<ns1:infoTable>
		<ns1:nameOfIssuer>INSPIRE MED SYS INC</ns1:nameOfIssuer>
		<ns1:titleOfClass>COM</ns1:titleOfClass>
		<ns1:cusip>457730109</ns1:cusip>
		<ns1:value>12786</ns1:value>
		<ns1:shrsOrPrnAmt>
			<ns1:sshPrnamt>172300</ns1:sshPrnamt>
			<ns1:sshPrnamtType>SH</ns1:sshPrnamtType>
		</ns1:shrsOrPrnAmt>
		<ns1:investmentDiscretion>DFND</ns1:investmentDiscretion>
		<ns1:otherManager>1</ns1:otherManager>
		<ns1:votingAuthority>
			<ns1:Sole>172300</ns1:Sole>
			<ns1:Shared>0</ns1:Shared>
			<ns1:None>0</ns1:None>
		</ns1:votingAuthority>
	</ns1:infoTable>
	<ns1:infoTable>
		<ns1:nameOfIssuer>KURA ONCOLOGY INC</ns1:nameOfIssuer>
		<ns1:titleOfClass>COM</ns1:titleOfClass>
		<ns1:cusip>50127T109</ns1:cusip>
		<ns1:value>13750</ns1:value>
		<ns1:shrsOrPrnAmt>
			<ns1:sshPrnamt>1000000</ns1:sshPrnamt>
			<ns1:sshPrnamtType>SH</ns1:sshPrnamtType>
		</ns1:shrsOrPrnAmt>
		<ns1:investmentDiscretion>DFND</ns1:investmentDiscretion>
		<ns1:otherManager>1</ns1:otherManager>
		<ns1:votingAuthority>
			<ns1:Sole>1000000</ns1:Sole>
			<ns1:Shared>0</ns1:Shared>
			<ns1:None>0</ns1:None>
		</ns1:votingAuthority>
	</ns1:infoTable>
	<ns1:infoTable>
		<ns1:nameOfIssuer>MERUS N V</ns1:nameOfIssuer>
		<ns1:titleOfClass>COM</ns1:titleOfClass>
		<ns1:cusip>N5749R100</ns1:cusip>
		<ns1:value>14080</ns1:value>
		<ns1:shrsOrPrnAmt>
			<ns1:sshPrnamt>1000000</ns1:sshPrnamt>
			<ns1:sshPrnamtType>SH</ns1:sshPrnamtType>
		</ns1:shrsOrPrnAmt>
		<ns1:investmentDiscretion>DFND</ns1:investmentDiscretion>
		<ns1:otherManager>1</ns1:otherManager>
		<ns1:votingAuthority>
			<ns1:Sole>1000000</ns1:Sole>
			<ns1:Shared>0</ns1:Shared>
			<ns1:None>0</ns1:None>
		</ns1:votingAuthority>
	</ns1:infoTable>
	<ns1:infoTable>
		<ns1:nameOfIssuer>MINERVA NEUROSCIENCES INC</ns1:nameOfIssuer>
		<ns1:titleOfClass>COM</ns1:titleOfClass>
		<ns1:cusip>603380106</ns1:cusip>
		<ns1:value>4322</ns1:value>
		<ns1:shrsOrPrnAmt>
			<ns1:sshPrnamt>607903</ns1:sshPrnamt>
			<ns1:sshPrnamtType>SH</ns1:sshPrnamtType>
		</ns1:shrsOrPrnAmt>
		<ns1:investmentDiscretion>DFND</ns1:investmentDiscretion>
		<ns1:otherManager>1</ns1:otherManager>
		<ns1:votingAuthority>
			<ns1:Sole>607903</ns1:Sole>
			<ns1:Shared>0</ns1:Shared>
			<ns1:None>0</ns1:None>
		</ns1:votingAuthority>
	</ns1:infoTable>
	<ns1:infoTable>
		<ns1:nameOfIssuer>MIRATI THERAPEUTICS INC</ns1:nameOfIssuer>
		<ns1:titleOfClass>COM</ns1:titleOfClass>
		<ns1:cusip>60468T105</ns1:cusip>
		<ns1:value>165249</ns1:value>
		<ns1:shrsOrPrnAmt>
			<ns1:sshPrnamt>1282392</ns1:sshPrnamt>
			<ns1:sshPrnamtType>SH</ns1:sshPrnamtType>
		</ns1:shrsOrPrnAmt>
		<ns1:investmentDiscretion>DFND</ns1:investmentDiscretion>
		<ns1:otherManager>1</ns1:otherManager>
		<ns1:votingAuthority>
			<ns1:Sole>1282392</ns1:Sole>
			<ns1:Shared>0</ns1:Shared>
			<ns1:None>0</ns1:None>
		</ns1:votingAuthority>
	</ns1:infoTable>
	<ns1:infoTable>
		<ns1:nameOfIssuer>MIRATI THERAPEUTICS INC</ns1:nameOfIssuer>
		<ns1:titleOfClass>COM</ns1:titleOfClass>
		<ns1:cusip>60468T105</ns1:cusip>
		<ns1:value>64430</ns1:value>
		<ns1:shrsOrPrnAmt>
			<ns1:sshPrnamt>500000</ns1:sshPrnamt>
			<ns1:sshPrnamtType>SH</ns1:sshPrnamtType>
		</ns1:shrsOrPrnAmt>
		<ns1:putCall>Call</ns1:putCall>
		<ns1:investmentDiscretion>DFND</ns1:investmentDiscretion>
		<ns1:otherManager>1</ns1:otherManager>
		<ns1:votingAuthority>
			<ns1:Sole>500000</ns1:Sole>
			<ns1:Shared>0</ns1:Shared>
			<ns1:None>0</ns1:None>
		</ns1:votingAuthority>
	</ns1:infoTable>
	<ns1:infoTable>
		<ns1:nameOfIssuer>MYOKARDIA INC</ns1:nameOfIssuer>
		<ns1:titleOfClass>COM</ns1:titleOfClass>
		<ns1:cusip>62857M105</ns1:cusip>
		<ns1:value>51020</ns1:value>
		<ns1:shrsOrPrnAmt>
			<ns1:sshPrnamt>700000</ns1:sshPrnamt>
			<ns1:sshPrnamtType>SH</ns1:sshPrnamtType>
		</ns1:shrsOrPrnAmt>
		<ns1:investmentDiscretion>DFND</ns1:investmentDiscretion>
		<ns1:otherManager>1</ns1:otherManager>
		<ns1:votingAuthority>
			<ns1:Sole>700000</ns1:Sole>
			<ns1:Shared>0</ns1:Shared>
			<ns1:None>0</ns1:None>
		</ns1:votingAuthority>
	</ns1:infoTable>
	<ns1:infoTable>
		<ns1:nameOfIssuer>MYOVANT SCIENCES LTD</ns1:nameOfIssuer>
		<ns1:titleOfClass>COM</ns1:titleOfClass>
		<ns1:cusip>G637AM102</ns1:cusip>
		<ns1:value>31040</ns1:value>
		<ns1:shrsOrPrnAmt>
			<ns1:sshPrnamt>2000000</ns1:sshPrnamt>
			<ns1:sshPrnamtType>SH</ns1:sshPrnamtType>
		</ns1:shrsOrPrnAmt>
		<ns1:investmentDiscretion>DFND</ns1:investmentDiscretion>
		<ns1:otherManager>1</ns1:otherManager>
		<ns1:votingAuthority>
			<ns1:Sole>2000000</ns1:Sole>
			<ns1:Shared>0</ns1:Shared>
			<ns1:None>0</ns1:None>
		</ns1:votingAuthority>
	</ns1:infoTable>
	<ns1:infoTable>
		<ns1:nameOfIssuer>NEKTAR THERAPEUTICS</ns1:nameOfIssuer>
		<ns1:titleOfClass>COM</ns1:titleOfClass>
		<ns1:cusip>640268108</ns1:cusip>
		<ns1:value>4317</ns1:value>
		<ns1:shrsOrPrnAmt>
			<ns1:sshPrnamt>200000</ns1:sshPrnamt>
			<ns1:sshPrnamtType>SH</ns1:sshPrnamtType>
		</ns1:shrsOrPrnAmt>
		<ns1:investmentDiscretion>DFND</ns1:investmentDiscretion>
		<ns1:otherManager>1</ns1:otherManager>
		<ns1:votingAuthority>
			<ns1:Sole>200000</ns1:Sole>
			<ns1:Shared>0</ns1:Shared>
			<ns1:None>0</ns1:None>
		</ns1:votingAuthority>
	</ns1:infoTable>
	<ns1:infoTable>
		<ns1:nameOfIssuer>NEUROCRINE BIOSCIENCES INC</ns1:nameOfIssuer>
		<ns1:titleOfClass>COM</ns1:titleOfClass>
		<ns1:cusip>64125C109</ns1:cusip>
		<ns1:value>4224</ns1:value>
		<ns1:shrsOrPrnAmt>
			<ns1:sshPrnamt>39300</ns1:sshPrnamt>
			<ns1:sshPrnamtType>SH</ns1:sshPrnamtType>
		</ns1:shrsOrPrnAmt>
		<ns1:investmentDiscretion>DFND</ns1:investmentDiscretion>
		<ns1:otherManager>1</ns1:otherManager>
		<ns1:votingAuthority>
			<ns1:Sole>39300</ns1:Sole>
			<ns1:Shared>0</ns1:Shared>
			<ns1:None>0</ns1:None>
		</ns1:votingAuthority>
	</ns1:infoTable>
	<ns1:infoTable>
		<ns1:nameOfIssuer>NEXTCURE INC</ns1:nameOfIssuer>
		<ns1:titleOfClass>COM</ns1:titleOfClass>
		<ns1:cusip>65343E108</ns1:cusip>
		<ns1:value>56330</ns1:value>
		<ns1:shrsOrPrnAmt>
			<ns1:sshPrnamt>1000000</ns1:sshPrnamt>
			<ns1:sshPrnamtType>SH</ns1:sshPrnamtType>
		</ns1:shrsOrPrnAmt>
		<ns1:investmentDiscretion>DFND</ns1:investmentDiscretion>
		<ns1:otherManager>1</ns1:otherManager>
		<ns1:votingAuthority>
			<ns1:Sole>1000000</ns1:Sole>
			<ns1:Shared>0</ns1:Shared>
			<ns1:None>0</ns1:None>
		</ns1:votingAuthority>
	</ns1:infoTable>
	<ns1:infoTable>
		<ns1:nameOfIssuer>OMEROS CORP</ns1:nameOfIssuer>
		<ns1:titleOfClass>COM</ns1:titleOfClass>
		<ns1:cusip>682143102</ns1:cusip>
		<ns1:value>21487</ns1:value>
		<ns1:shrsOrPrnAmt>
			<ns1:sshPrnamt>1525000</ns1:sshPrnamt>
			<ns1:sshPrnamtType>SH</ns1:sshPrnamtType>
		</ns1:shrsOrPrnAmt>
		<ns1:investmentDiscretion>DFND</ns1:investmentDiscretion>
		<ns1:otherManager>1</ns1:otherManager>
		<ns1:votingAuthority>
			<ns1:Sole>1525000</ns1:Sole>
			<ns1:Shared>0</ns1:Shared>
			<ns1:None>0</ns1:None>
		</ns1:votingAuthority>
	</ns1:infoTable>
	<ns1:infoTable>
		<ns1:nameOfIssuer>ORCHARD THERAPEUTICS PLC</ns1:nameOfIssuer>
		<ns1:titleOfClass>ADS</ns1:titleOfClass>
		<ns1:cusip>68570P101</ns1:cusip>
		<ns1:value>4815</ns1:value>
		<ns1:shrsOrPrnAmt>
			<ns1:sshPrnamt>350203</ns1:sshPrnamt>
			<ns1:sshPrnamtType>SH</ns1:sshPrnamtType>
		</ns1:shrsOrPrnAmt>
		<ns1:investmentDiscretion>DFND</ns1:investmentDiscretion>
		<ns1:otherManager>1</ns1:otherManager>
		<ns1:votingAuthority>
			<ns1:Sole>350203</ns1:Sole>
			<ns1:Shared>0</ns1:Shared>
			<ns1:None>0</ns1:None>
		</ns1:votingAuthority>
	</ns1:infoTable>
	<ns1:infoTable>
		<ns1:nameOfIssuer>OUTLOOK THERAPEUTICS INC</ns1:nameOfIssuer>
		<ns1:titleOfClass>*W EXP 02/18/202</ns1:titleOfClass>
		<ns1:cusip>69012T115</ns1:cusip>
		<ns1:value>27</ns1:value>
		<ns1:shrsOrPrnAmt>
			<ns1:sshPrnamt>416666</ns1:sshPrnamt>
			<ns1:sshPrnamtType>SH</ns1:sshPrnamtType>
		</ns1:shrsOrPrnAmt>
		<ns1:investmentDiscretion>DFND</ns1:investmentDiscretion>
		<ns1:otherManager>1</ns1:otherManager>
		<ns1:votingAuthority>
			<ns1:Sole>416666</ns1:Sole>
			<ns1:Shared>0</ns1:Shared>
			<ns1:None>0</ns1:None>
		</ns1:votingAuthority>
	</ns1:infoTable>
	<ns1:infoTable>
		<ns1:nameOfIssuer>PRECISION BIOSCIENCES INC</ns1:nameOfIssuer>
		<ns1:titleOfClass>COM</ns1:titleOfClass>
		<ns1:cusip>74019P108</ns1:cusip>
		<ns1:value>6494</ns1:value>
		<ns1:shrsOrPrnAmt>
			<ns1:sshPrnamt>467516</ns1:sshPrnamt>
			<ns1:sshPrnamtType>SH</ns1:sshPrnamtType>
		</ns1:shrsOrPrnAmt>
		<ns1:investmentDiscretion>DFND</ns1:investmentDiscretion>
		<ns1:otherManager>1</ns1:otherManager>
		<ns1:votingAuthority>
			<ns1:Sole>467512</ns1:Sole>
			<ns1:Shared>0</ns1:Shared>
			<ns1:None>0</ns1:None>
		</ns1:votingAuthority>
	</ns1:infoTable>
	<ns1:infoTable>
		<ns1:nameOfIssuer>PRINCIPIA BIOPHARMA INC</ns1:nameOfIssuer>
		<ns1:titleOfClass>COM</ns1:titleOfClass>
		<ns1:cusip>74257L108</ns1:cusip>
		<ns1:value>109063</ns1:value>
		<ns1:shrsOrPrnAmt>
			<ns1:sshPrnamt>1990922</ns1:sshPrnamt>
			<ns1:sshPrnamtType>SH</ns1:sshPrnamtType>
		</ns1:shrsOrPrnAmt>
		<ns1:investmentDiscretion>DFND</ns1:investmentDiscretion>
		<ns1:otherManager>1</ns1:otherManager>
		<ns1:votingAuthority>
			<ns1:Sole>1990922</ns1:Sole>
			<ns1:Shared>0</ns1:Shared>
			<ns1:None>0</ns1:None>
		</ns1:votingAuthority>
	</ns1:infoTable>
	<ns1:infoTable>
		<ns1:nameOfIssuer>QUOTIENT LTD</ns1:nameOfIssuer>
		<ns1:titleOfClass>SHS</ns1:titleOfClass>
		<ns1:cusip>G73268107</ns1:cusip>
		<ns1:value>33285</ns1:value>
		<ns1:shrsOrPrnAmt>
			<ns1:sshPrnamt>3500000</ns1:sshPrnamt>
			<ns1:sshPrnamtType>SH</ns1:sshPrnamtType>
		</ns1:shrsOrPrnAmt>
		<ns1:investmentDiscretion>DFND</ns1:investmentDiscretion>
		<ns1:otherManager>1</ns1:otherManager>
		<ns1:votingAuthority>
			<ns1:Sole>3500000</ns1:Sole>
			<ns1:Shared>0</ns1:Shared>
			<ns1:None>0</ns1:None>
		</ns1:votingAuthority>
	</ns1:infoTable>
	<ns1:infoTable>
		<ns1:nameOfIssuer>RA PHARMACEUTICALS INC</ns1:nameOfIssuer>
		<ns1:titleOfClass>COM</ns1:titleOfClass>
		<ns1:cusip>74933V108</ns1:cusip>
		<ns1:value>13873</ns1:value>
		<ns1:shrsOrPrnAmt>
			<ns1:sshPrnamt>295600</ns1:sshPrnamt>
			<ns1:sshPrnamtType>SH</ns1:sshPrnamtType>
		</ns1:shrsOrPrnAmt>
		<ns1:investmentDiscretion>DFND</ns1:investmentDiscretion>
		<ns1:otherManager>1</ns1:otherManager>
		<ns1:votingAuthority>
			<ns1:Sole>295600</ns1:Sole>
			<ns1:Shared>0</ns1:Shared>
			<ns1:None>0</ns1:None>
		</ns1:votingAuthority>
	</ns1:infoTable>
	<ns1:infoTable>
		<ns1:nameOfIssuer>REATA PHARMACEUTICALS INC</ns1:nameOfIssuer>
		<ns1:titleOfClass>CL A</ns1:titleOfClass>
		<ns1:cusip>75615P103</ns1:cusip>
		<ns1:value>166897</ns1:value>
		<ns1:shrsOrPrnAmt>
			<ns1:sshPrnamt>816400</ns1:sshPrnamt>
			<ns1:sshPrnamtType>SH</ns1:sshPrnamtType>
		</ns1:shrsOrPrnAmt>
		<ns1:investmentDiscretion>DFND</ns1:investmentDiscretion>
		<ns1:otherManager>1</ns1:otherManager>
		<ns1:votingAuthority>
			<ns1:Sole>816400</ns1:Sole>
			<ns1:Shared>0</ns1:Shared>
			<ns1:None>0</ns1:None>
		</ns1:votingAuthority>
	</ns1:infoTable>
	<ns1:infoTable>
		<ns1:nameOfIssuer>REATA PHARMACEUTICALS INC</ns1:nameOfIssuer>
		<ns1:titleOfClass>CL A</ns1:titleOfClass>
		<ns1:cusip>75615P103</ns1:cusip>
		<ns1:value>51108</ns1:value>
		<ns1:shrsOrPrnAmt>
			<ns1:sshPrnamt>250000</ns1:sshPrnamt>
			<ns1:sshPrnamtType>SH</ns1:sshPrnamtType>
		</ns1:shrsOrPrnAmt>
		<ns1:putCall>Call</ns1:putCall>
		<ns1:investmentDiscretion>DFND</ns1:investmentDiscretion>
		<ns1:otherManager>1</ns1:otherManager>
		<ns1:votingAuthority>
			<ns1:Sole>250000</ns1:Sole>
			<ns1:Shared>0</ns1:Shared>
			<ns1:None>0</ns1:None>
		</ns1:votingAuthority>
	</ns1:infoTable>
	<ns1:infoTable>
		<ns1:nameOfIssuer>ROCKET PHARMACEUTICALS INC</ns1:nameOfIssuer>
		<ns1:titleOfClass>COM</ns1:titleOfClass>
		<ns1:cusip>77313F106</ns1:cusip>
		<ns1:value>41816</ns1:value>
		<ns1:shrsOrPrnAmt>
			<ns1:sshPrnamt>1837269</ns1:sshPrnamt>
			<ns1:sshPrnamtType>SH</ns1:sshPrnamtType>
		</ns1:shrsOrPrnAmt>
		<ns1:investmentDiscretion>DFND</ns1:investmentDiscretion>
		<ns1:otherManager>1</ns1:otherManager>
		<ns1:votingAuthority>
			<ns1:Sole>1837269</ns1:Sole>
			<ns1:Shared>0</ns1:Shared>
			<ns1:None>0</ns1:None>
		</ns1:votingAuthority>
	</ns1:infoTable>
	<ns1:infoTable>
		<ns1:nameOfIssuer>SAREPTA THERAPEUTICS INC</ns1:nameOfIssuer>
		<ns1:titleOfClass>COM</ns1:titleOfClass>
		<ns1:cusip>803607100</ns1:cusip>
		<ns1:value>32260</ns1:value>
		<ns1:shrsOrPrnAmt>
			<ns1:sshPrnamt>250000</ns1:sshPrnamt>
			<ns1:sshPrnamtType>SH</ns1:sshPrnamtType>
		</ns1:shrsOrPrnAmt>
		<ns1:investmentDiscretion>DFND</ns1:investmentDiscretion>
		<ns1:otherManager>1</ns1:otherManager>
		<ns1:votingAuthority>
			<ns1:Sole>250000</ns1:Sole>
			<ns1:Shared>0</ns1:Shared>
			<ns1:None>0</ns1:None>
		</ns1:votingAuthority>
	</ns1:infoTable>
	<ns1:infoTable>
		<ns1:nameOfIssuer>SATSUMA PHARMACEUTICALS INC</ns1:nameOfIssuer>
		<ns1:titleOfClass>COM</ns1:titleOfClass>
		<ns1:cusip>80405P107</ns1:cusip>
		<ns1:value>16893</ns1:value>
		<ns1:shrsOrPrnAmt>
			<ns1:sshPrnamt>858382</ns1:sshPrnamt>
			<ns1:sshPrnamtType>SH</ns1:sshPrnamtType>
		</ns1:shrsOrPrnAmt>
		<ns1:investmentDiscretion>DFND</ns1:investmentDiscretion>
		<ns1:otherManager>1</ns1:otherManager>
		<ns1:votingAuthority>
			<ns1:Sole>858382</ns1:Sole>
			<ns1:Shared>0</ns1:Shared>
			<ns1:None>0</ns1:None>
		</ns1:votingAuthority>
	</ns1:infoTable>
	<ns1:infoTable>
		<ns1:nameOfIssuer>SORRENTO THERAPEUTICS INC</ns1:nameOfIssuer>
		<ns1:titleOfClass>COM NEW</ns1:titleOfClass>
		<ns1:cusip>83587F202</ns1:cusip>
		<ns1:value>13520</ns1:value>
		<ns1:shrsOrPrnAmt>
			<ns1:sshPrnamt>4000000</ns1:sshPrnamt>
			<ns1:sshPrnamtType>SH</ns1:sshPrnamtType>
		</ns1:shrsOrPrnAmt>
		<ns1:investmentDiscretion>DFND</ns1:investmentDiscretion>
		<ns1:otherManager>1</ns1:otherManager>
		<ns1:votingAuthority>
			<ns1:Sole>4000000</ns1:Sole>
			<ns1:Shared>0</ns1:Shared>
			<ns1:None>0</ns1:None>
		</ns1:votingAuthority>
	</ns1:infoTable>
	<ns1:infoTable>
		<ns1:nameOfIssuer>SPDR SERIES TRUST</ns1:nameOfIssuer>
		<ns1:titleOfClass>S&amp;P BIOTECH</ns1:titleOfClass>
		<ns1:cusip>78464A870</ns1:cusip>
		<ns1:value>47555</ns1:value>
		<ns1:shrsOrPrnAmt>
			<ns1:sshPrnamt>500000</ns1:sshPrnamt>
			<ns1:sshPrnamtType>SH</ns1:sshPrnamtType>
		</ns1:shrsOrPrnAmt>
		<ns1:putCall>Put</ns1:putCall>
		<ns1:investmentDiscretion>DFND</ns1:investmentDiscretion>
		<ns1:otherManager>1</ns1:otherManager>
		<ns1:votingAuthority>
			<ns1:Sole>500000</ns1:Sole>
			<ns1:Shared>0</ns1:Shared>
			<ns1:None>0</ns1:None>
		</ns1:votingAuthority>
	</ns1:infoTable>
	<ns1:infoTable>
		<ns1:nameOfIssuer>STOKE THERAPEUTICS INC</ns1:nameOfIssuer>
		<ns1:titleOfClass>COM</ns1:titleOfClass>
		<ns1:cusip>86150R107</ns1:cusip>
		<ns1:value>50654</ns1:value>
		<ns1:shrsOrPrnAmt>
			<ns1:sshPrnamt>1788643</ns1:sshPrnamt>
			<ns1:sshPrnamtType>SH</ns1:sshPrnamtType>
		</ns1:shrsOrPrnAmt>
		<ns1:investmentDiscretion>DFND</ns1:investmentDiscretion>
		<ns1:otherManager>1</ns1:otherManager>
		<ns1:votingAuthority>
			<ns1:Sole>1788643</ns1:Sole>
			<ns1:Shared>0</ns1:Shared>
			<ns1:None>0</ns1:None>
		</ns1:votingAuthority>
	</ns1:infoTable>
	<ns1:infoTable>
		<ns1:nameOfIssuer>THERAVANCE BIOPHARMA INC</ns1:nameOfIssuer>
		<ns1:titleOfClass>COM</ns1:titleOfClass>
		<ns1:cusip>G8807B106</ns1:cusip>
		<ns1:value>1295</ns1:value>
		<ns1:shrsOrPrnAmt>
			<ns1:sshPrnamt>50000</ns1:sshPrnamt>
			<ns1:sshPrnamtType>SH</ns1:sshPrnamtType>
		</ns1:shrsOrPrnAmt>
		<ns1:investmentDiscretion>DFND</ns1:investmentDiscretion>
		<ns1:otherManager>1</ns1:otherManager>
		<ns1:votingAuthority>
			<ns1:Sole>50000</ns1:Sole>
			<ns1:Shared>0</ns1:Shared>
			<ns1:None>0</ns1:None>
		</ns1:votingAuthority>
	</ns1:infoTable>
	<ns1:infoTable>
		<ns1:nameOfIssuer>TRICIDA INC</ns1:nameOfIssuer>
		<ns1:titleOfClass>COM</ns1:titleOfClass>
		<ns1:cusip>89610F101</ns1:cusip>
		<ns1:value>35022</ns1:value>
		<ns1:shrsOrPrnAmt>
			<ns1:sshPrnamt>927975</ns1:sshPrnamt>
			<ns1:sshPrnamtType>SH</ns1:sshPrnamtType>
		</ns1:shrsOrPrnAmt>
		<ns1:investmentDiscretion>DFND</ns1:investmentDiscretion>
		<ns1:otherManager>1</ns1:otherManager>
		<ns1:votingAuthority>
			<ns1:Sole>927975</ns1:Sole>
			<ns1:Shared>0</ns1:Shared>
			<ns1:None>0</ns1:None>
		</ns1:votingAuthority>
	</ns1:infoTable>
	<ns1:infoTable>
		<ns1:nameOfIssuer>TURNING POINT THERAPEUTICS I</ns1:nameOfIssuer>
		<ns1:titleOfClass>COM</ns1:titleOfClass>
		<ns1:cusip>90041T108</ns1:cusip>
		<ns1:value>211577</ns1:value>
		<ns1:shrsOrPrnAmt>
			<ns1:sshPrnamt>3396650</ns1:sshPrnamt>
			<ns1:sshPrnamtType>SH</ns1:sshPrnamtType>
		</ns1:shrsOrPrnAmt>
		<ns1:investmentDiscretion>DFND</ns1:investmentDiscretion>
		<ns1:otherManager>1</ns1:otherManager>
		<ns1:votingAuthority>
			<ns1:Sole>3396650</ns1:Sole>
			<ns1:Shared>0</ns1:Shared>
			<ns1:None>0</ns1:None>
		</ns1:votingAuthority>
	</ns1:infoTable>
	<ns1:infoTable>
		<ns1:nameOfIssuer>TWIST BIOSCIENCE CORP</ns1:nameOfIssuer>
		<ns1:titleOfClass>COM</ns1:titleOfClass>
		<ns1:cusip>90184D100</ns1:cusip>
		<ns1:value>14430</ns1:value>
		<ns1:shrsOrPrnAmt>
			<ns1:sshPrnamt>687149</ns1:sshPrnamt>
			<ns1:sshPrnamtType>SH</ns1:sshPrnamtType>
		</ns1:shrsOrPrnAmt>
		<ns1:investmentDiscretion>DFND</ns1:investmentDiscretion>
		<ns1:otherManager>1</ns1:otherManager>
		<ns1:votingAuthority>
			<ns1:Sole>687149</ns1:Sole>
			<ns1:Shared>0</ns1:Shared>
			<ns1:None>0</ns1:None>
		</ns1:votingAuthority>
	</ns1:infoTable>
	<ns1:infoTable>
		<ns1:nameOfIssuer>UNIQURE NV</ns1:nameOfIssuer>
		<ns1:titleOfClass>SHS</ns1:titleOfClass>
		<ns1:cusip>N90064101</ns1:cusip>
		<ns1:value>28664</ns1:value>
		<ns1:shrsOrPrnAmt>
			<ns1:sshPrnamt>400000</ns1:sshPrnamt>
			<ns1:sshPrnamtType>SH</ns1:sshPrnamtType>
		</ns1:shrsOrPrnAmt>
		<ns1:investmentDiscretion>DFND</ns1:investmentDiscretion>
		<ns1:otherManager>1</ns1:otherManager>
		<ns1:votingAuthority>
			<ns1:Sole>400000</ns1:Sole>
			<ns1:Shared>0</ns1:Shared>
			<ns1:None>0</ns1:None>
		</ns1:votingAuthority>
	</ns1:infoTable>
	<ns1:infoTable>
		<ns1:nameOfIssuer>VIELA BIO INC</ns1:nameOfIssuer>
		<ns1:titleOfClass>COM</ns1:titleOfClass>
		<ns1:cusip>926613100</ns1:cusip>
		<ns1:value>40657</ns1:value>
		<ns1:shrsOrPrnAmt>
			<ns1:sshPrnamt>1497500</ns1:sshPrnamt>
			<ns1:sshPrnamtType>SH</ns1:sshPrnamtType>
		</ns1:shrsOrPrnAmt>
		<ns1:investmentDiscretion>DFND</ns1:investmentDiscretion>
		<ns1:otherManager>1</ns1:otherManager>
		<ns1:votingAuthority>
			<ns1:Sole>1497500</ns1:Sole>
			<ns1:Shared>0</ns1:Shared>
			<ns1:None>0</ns1:None>
		</ns1:votingAuthority>
	</ns1:infoTable>
	<ns1:infoTable>
		<ns1:nameOfIssuer>X4 PHARMACEUTICALS INC</ns1:nameOfIssuer>
		<ns1:titleOfClass>COM</ns1:titleOfClass>
		<ns1:cusip>98420X103</ns1:cusip>
		<ns1:value>2704</ns1:value>
		<ns1:shrsOrPrnAmt>
			<ns1:sshPrnamt>252747</ns1:sshPrnamt>
			<ns1:sshPrnamtType>SH</ns1:sshPrnamtType>
		</ns1:shrsOrPrnAmt>
		<ns1:investmentDiscretion>DFND</ns1:investmentDiscretion>
		<ns1:otherManager>1</ns1:otherManager>
		<ns1:votingAuthority>
			<ns1:Sole>252747</ns1:Sole>
			<ns1:Shared>0</ns1:Shared>
			<ns1:None>0</ns1:None>
		</ns1:votingAuthority>
	</ns1:infoTable>
	<ns1:infoTable>
		<ns1:nameOfIssuer>Y-MABS THERAPEUTICS INC</ns1:nameOfIssuer>
		<ns1:titleOfClass>COM</ns1:titleOfClass>
		<ns1:cusip>984241109</ns1:cusip>
		<ns1:value>50074</ns1:value>
		<ns1:shrsOrPrnAmt>
			<ns1:sshPrnamt>1602376</ns1:sshPrnamt>
			<ns1:sshPrnamtType>SH</ns1:sshPrnamtType>
		</ns1:shrsOrPrnAmt>
		<ns1:investmentDiscretion>DFND</ns1:investmentDiscretion>
		<ns1:otherManager>1</ns1:otherManager>
		<ns1:votingAuthority>
			<ns1:Sole>1602376</ns1:Sole>
			<ns1:Shared>0</ns1:Shared>
			<ns1:None>0</ns1:None>
		</ns1:votingAuthority>
	</ns1:infoTable>
	<ns1:infoTable>
		<ns1:nameOfIssuer>ZAI LAB LTD</ns1:nameOfIssuer>
		<ns1:titleOfClass>ADR</ns1:titleOfClass>
		<ns1:cusip>98887Q104</ns1:cusip>
		<ns1:value>11527</ns1:value>
		<ns1:shrsOrPrnAmt>
			<ns1:sshPrnamt>277161</ns1:sshPrnamt>
			<ns1:sshPrnamtType>SH</ns1:sshPrnamtType>
		</ns1:shrsOrPrnAmt>
		<ns1:investmentDiscretion>DFND</ns1:investmentDiscretion>
		<ns1:otherManager>1</ns1:otherManager>
		<ns1:votingAuthority>
			<ns1:Sole>277161</ns1:Sole>
			<ns1:Shared>0</ns1:Shared>
			<ns1:None>0</ns1:None>
		</ns1:votingAuthority>
	</ns1:infoTable>
	<ns1:infoTable>
		<ns1:nameOfIssuer>ZYMEWORKS INC</ns1:nameOfIssuer>
		<ns1:titleOfClass>COM</ns1:titleOfClass>
		<ns1:cusip>98985W102</ns1:cusip>
		<ns1:value>31822</ns1:value>
		<ns1:shrsOrPrnAmt>
			<ns1:sshPrnamt>700000</ns1:sshPrnamt>
			<ns1:sshPrnamtType>SH</ns1:sshPrnamtType>
		</ns1:shrsOrPrnAmt>
		<ns1:investmentDiscretion>DFND</ns1:investmentDiscretion>
		<ns1:otherManager>1</ns1:otherManager>
		<ns1:votingAuthority>
			<ns1:Sole>700000</ns1:Sole>
			<ns1:Shared>0</ns1:Shared>
			<ns1:None>0</ns1:None>
		</ns1:votingAuthority>
	</ns1:infoTable>
</ns1:informationTable>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
